Millendo, OvaScience merge, raise $50M

Millendo, OvaScience merge, raise $50M

Source: 
BioCentury
snippet: 

Emerging from the reverse-merger of private endocrine company Millendo Therapeutics Inc. and former public fertility company OvaScience Inc., Millendo Therapeutics Inc. (NASDAQ:MLND) raised $49.5 million in a financing Friday. The combined company will begin trading Monday.